In this interview conducted at the Society for Neuroscience’s Neuroscience 2023, we explore the fascinating world of neuroscience with Professor Michael Stryker, a leading expert with over four decades of groundbreaking research.
Internal documents shed new light on Sarepta FDA decision, which top agency official says was ‘exceptional’
While he has repeatedly advocated for accelerated gene therapy approvals, the FDA’s top cell and gene therapy official Peter Marks said that the agency’s landmark